Thomas Woiwode

Insider Reports History

Identity Who this page is about. 1 identity field
Location
San Francisco, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Owner filing signature
/s/ Edgar Cale, Attorney-in-Fact
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction evidence
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Thomas Woiwode

Form 4 holding Director

Gritstone bio, Inc.

Security class
Common Stock
Shares / value
128
Estimated value
$244
Report date
25 Aug 2021
Price
$1.90
Ownership
Direct
Form 4 holding Director

Adverum Biotechnologies, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
40,000
Estimated value
Report date
12 May 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director, 10%+ Owner

Passage BIO, Inc.

Security class
Director Stock Option (Right to Buy)
Shares / value
24,000
Estimated value
Report date
25 May 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Aligos Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
15,000
Estimated value
Report date
23 Jun 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Tempest Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
3,500
Estimated value
Report date
17 Jun 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Gritstone bio, Inc.

Security class
Common Stock
Shares / value
0
Estimated value
Report date
25 Aug 2021
Price
$1.90
Ownership
Indirect

Insider Reports Filed by Thomas Woiwode

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .